Alternatives to BenevolentAI
Compare BenevolentAI alternatives for your business or organization using the curated list below. SourceForge ranks the best alternatives to BenevolentAI in 2026. Compare features, ratings, user reviews, pricing, and more from BenevolentAI competitors and alternatives in order to make an informed decision for your business.
-
1
SYNTHIA Retrosynthesis Software
Merck KGaA
Expert-coded by chemists and engineered by computer scientists, SYNTHIA™ Retrosynthesis Software enables scientists to quickly find and easily navigate innovative and novel pathways for novel and published target molecules. Quickly and efficiently scan hundreds of pathways to help you identify the best option according to your needs. Explore the most cost-effective routes to your target molecules with state of the art visualization and filtering options. Easily customize search parameters to eliminate or promote reactions, reagents or classes of molecules. Explore unique and innovative syntheses that may be unknown for building your desired molecule. Easily generate a list of commercially available starting materials for your synthesis. Benefit from ISO/IEC 27001 Information Security Certification to guarantee the confidentiality, integrity, and protection of your data.Starting Price: €0 / 30 days -
2
SciSpace BioMed Agent
SciSpace
SciSpace BioMed is a domain-native AI “co-scientist” for biomedical research that combines a vast literature database with 150+ integrated bio-tools and 100+ academic databases and software suites to streamline complex research workflows, from genomics and single-cell analysis to drug discovery and clinical genomics. It enables researchers to ask natural-language questions, ingest datasets, interpret variants or multi-omics data, design cloning or wet-lab workflows, reason about clinical or disease biology, and generate publication-ready outputs (e.g., figures, tables, and presentations) with full transparency and citations. Users can interact with scientific papers via “chat with PDF,” highlight confusing text, math, or tables, and get clear explanations, ideal for understanding difficult methods or concepts. For literature review or exploratory research, its AI-driven semantic search accesses millions of papers and returns citation-backed summaries.Starting Price: $12 per month -
3
Causaly
Causaly
Leverage the power of AI to expedite the journey from bench research and laboratory insights to the launch of life-changing therapies. Gain up to 90% in research productivity by reducing your reading time from months to minutes. Cut through the noise with a high-precision, high-accuracy search to navigate the ever-growing volume of scientific literature with ease. Save time, reduce bias and increase odds of novel discoveries. Deeply explore disease biology and conduct advanced target discovery. Causaly’s high-precision knowledge graph consolidates evidence from millions of publications, making deep, unbiased scientific exploration possible. Rapidly navigate biological cause-and-effect relationships without being an expert. Get a view of all scientific documents and uncover hidden connections. Causaly’s powerful AI machine reads millions of published biomedical literature to support better decision-making and research outcomes. -
4
Recursion
Recursion
Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models. -
5
Scitara DLX
Scitara
Scitara DLX™ offers a rapid connectivity infrastructure for any instrument in the life science laboratory in a fully compliant and auditable cloud-based platform. Scitara DLX™ is a universal digital data infrastructure that connects any instrument, resource, app and software in the laboratory. The cloud-based, fully auditable platform connects all data sources across the lab, allowing the free flow of data across multiple end points. This allows scientists to devote their time to scientific research, not waste it solving data issues. DLX curates and corrects data in flight to support the development of accurate, properly structured data models that feed AI and ML systems. This supports a successful digital transformation strategy in the pharma and biopharma industries. Unlocking insights from scientific data enables faster decision-making in drug discovery and development, helping bring drugs to market more quickly. -
6
AWS HealthOmics
Amazon
Securely combine the multiomic data of individuals with their medical history to deliver more personalized care. Use purpose-built data stores to support large-scale analysis and collaborative research across entire populations. Accelerate research by using scalable workflows and integrated computation tools. Protect patient privacy with HIPAA eligibility and built-in data access and logging. AWS HealthOmics helps healthcare and life science organizations and their software partners store, query, and analyze genomic, transcriptomic, and other omics data and then generate insights from that data to improve health and advance scientific discoveries. Store and analyze omics data for hundreds of thousands of patients to understand how omics variation maps to phenotypes across a population. Build reproducible and traceable clinical multiomics workflows to reduce turnaround times and increase productivity. Integrate multiomic analysis into clinical trials to test new drug candidates. -
7
NVIDIA Clara
NVIDIA
Clara’s domain-specific tools, AI pre-trained models, and accelerated applications are enabling AI breakthroughs in numerous fields, including medical devices, imaging, drug discovery, and genomics. Explore the end-to-end pipeline of medical device development and deployment with the Holoscan platform. Build containerized AI apps with the Holoscan SDK and MONAI, and streamline deployment in next-generation AI devices with the NVIDIA IGX developer kits. The NVIDIA Holoscan SDK includes healthcare-specific acceleration libraries, pre-trained AI models, and reference applications for computational medical devices. -
8
Correlation Engine
Illumina
Correlation Engine is an interactive omics knowledgebase that puts private omics data in a biological context with highly curated public data. One of the largest biological databases in the world, Correlation Engine provides life science researchers with unprecedented access to vast numbers of high-quality whole-genome analyses and insightful scientific tools. The knowledgebase enables novel discoveries by interrogating billions of data points derived from standardized analyses of whole genome studies. A suite of applications to determine biological context, a continually growing library of curated data sets, and support for multiple species and multi-omic datasets. Utilize a simple graphical user interface to leverage guided workflows, push-button applications, and APIs. Accelerate your journey from omic data to decision and get access to over 25,000 multi-omics studies (from over 250,000 signatures) that have been reanalyzed. -
9
BIOVIA Discovery Studio
Dassault Systèmes
Today’s biopharmaceutical industry is marked by complexity: growing market demands for improved specificity and safety, novel treatment classes and more intricate mechanisms of disease. Keeping up with this complexity requires a deeper understanding of therapeutic behavior. Modeling and simulation methods provide a unique means to explore biological and physicochemical processes down to the atomic level. This can guide physical experimentation, accelerating the discovery and development process. BIOVIA Discovery Studio brings together over 30 years of peer-reviewed research and world-class in silico techniques such as molecular mechanics, free energy calculations, biotherapeutics developability and more into a common environment. It provides researchers with a complete toolset to explore the nuances of protein chemistry and catalyze discovery of small and large molecule therapeutics from Target ID to Lead Optimization. -
10
Atomwise
Atomwise
We use our AI engine to transform drug discovery. Our discoveries help create better medicines faster. Our AI-enabled discovery portfolio includes wholly-owned and co-developed pipeline assets, and is backed by prominent investors. Atomwise developed a machine-learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small-molecule medicines. The secret to reinventing drug discovery with AI is people. We are dedicated to developing the best AI platform and using it to transform small molecule drug discovery. We have to tackle the most challenging, seemingly impossible targets and streamline the drug discovery process to give drug developers more shots on goal. Computational efficiency enables screening of trillions of compounds in silico, increasing the likelihood of success. Demonstrated exquisite model accuracy, overcoming the challenge of false positives. -
11
FutureHouse
FutureHouse
FutureHouse is a nonprofit AI research lab focused on automating scientific discovery in biology and other complex sciences. FutureHouse features superintelligent AI agents designed to assist scientists in accelerating research processes. It is optimized for retrieving and summarizing information from scientific literature, achieving state-of-the-art performance on benchmarks like RAG-QA Arena's science benchmark. It employs an agentic approach, allowing for iterative query expansion, LLM re-ranking, contextual summarization, and document citation traversal to enhance retrieval accuracy. FutureHouse also offers a framework for training language agents on challenging scientific tasks, enabling agents to perform tasks such as protein engineering, literature summarization, and molecular cloning. Their LAB-Bench benchmark evaluates language models on biology research tasks, including information extraction, database retrieval, etc. -
12
Genedata Biologics
Genedata
Genedata Biologics® streamlines discovery of biotherapeutics including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. The most widely adopted platform across the industry, it integrates all discovery workflows so you can focus on true innovation. Accelerate research with a first-in-class platform uniquely designed from the start to digitalize biotherapeutic discovery. The platform facilitates complex R&D processes by designing, tracking, testing, and assessing novel biotherapeutics drugs. It works with any format, from antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, to engineered therapeutic cell lines such as TCRs and CAR-T cells. Acting as a central end-to-end data backbone, Genedata Biologics integrates all R&D processes, from library design and immunizations, selections and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, to candidate developability and manufacturability assessments. -
13
DNAnexus Apollo
DNAnexus
DNAnexus Apollo™ accelerates precision drug discovery by unlocking the power of collaboration to draw critical insights from omics data. Precision drug discovery requires collecting and analyzing huge volumes of omics and clinical data. These datasets are incredibly rich resources, but most legacy and home-grown informatics tools can't cope with their size and complexity. Precision medicine programs can also be hampered by siloed data sources, underpowered collaboration tools, and the burden of complex and always changing regulatory and security requirements. DNAnexus Apollo™ supports precision drug discovery programs by empowering scientists and clinicians to explore and analyze omics and clinical data together, in a single environment, built on a robust, scalable cloud platform. Apollo lets them share data, tools, and analyses easily and securely with peers and collaborators everywhere - whether they're on another floor, or another continent. -
14
AlphaFold
DeepMind
These exquisite, intricate machines are proteins. They underpin not just the biological processes in your body but every biological process in every living thing. They’re the building blocks of life. Currently, there are around 100 million known distinct proteins, with many more found every year. Each one has a unique 3D shape that determines how it works and what it does. But figuring out the exact structure of a protein remains an expensive and often time-consuming process, meaning we only know the exact 3D structure of a tiny fraction of the proteins known to science. Finding a way to close this rapidly expanding gap and predict the structure of millions of unknown proteins could not only help us tackle disease and more quickly find new medicines but perhaps also unlock the mysteries of how life itself works. -
15
Bruker Drug Discovery
Bruker
Bringing a new drug into the market, from the first step to the final market introduction, is a time-consuming, highly regulated, and expensive process, which can take a decade or more. Final success crucially depends on the early availability of accurate analytical results, fast enough for taking the right decisions at the beginning of the development and minimizing late attrition rates. Today’s drug development is mainly based on a rational approach where typically establishing the biological target to focus on is the first key step. This target identification requires a deep understanding of the candidates´ properties to identify the most promising ones as quickly and reliable as possible. Once a biological target has been established, finding the most promising lead molecules is often seen as the next challenge. Typically, lead discovery is the identification of potential drug candidates – either small organic molecules or biologic assemblies with therapeutic potential. -
16
Genospace
Genospace
At Genospace, we understand that genomics is driving the development of precision medicine, yet scaling its delivery is an unsolved challenge. We’re here to help. Our platform is designed to make biomedical data meaningful and accessible to everyone, especially those on the front lines of care delivery. Arm your clinicians and researchers with the information they need to make informed decisions and join us in our mission of leveraging high-dimensional molecular data to improve individual patient outcomes and accelerate drug development and research. Large-scale population data is necessary for drug development and research. Conduct cohort-driven analyses to inform your research activities with the Genospace platform. We specialize in clinical trial research. Use the Genospace platform to match fragmented patient data to complex trial criteria and expedite patient accruals. Integrate genomic medicine into mainstream clinical care with the Genospace platform. -
17
NVIDIA BioNeMo
NVIDIA
BioNeMo is an AI-powered drug discovery cloud service and framework built on NVIDIA NeMo Megatron for training and deploying large biomolecular transformer AI models at a supercomputing scale. The service includes pre-trained large language models (LLMs) and native support for common file formats for proteins, DNA, RNA, and chemistry, providing data loaders for SMILES for molecular structures and FASTA for amino acid and nucleotide sequences. The BioNeMo framework will also be available for download for running on your own infrastructure. ESM-1, based on Meta AI’s state-of-the-art ESM-1b, and ProtT5 are transformer-based protein language models that can be used to generate learned embeddings for tasks like protein structure and property prediction. OpenFold, a deep learning model for 3D structure prediction of novel protein sequences, will be available in BioNeMo service. -
18
CoVigilAI
CoVigilAI
CoVigilAI is an AI-enabled medical literature monitoring solution that employs advanced algorithms and data analytics to proactively detect and manage adverse drug events, ensuring patient safety and regulatory compliance in real time. The platform offers streamlined tracking of scientific and medical publications across prominent global literature databases such as PubMed and Embase, with customizable search strings facilitating an effortless pharmacovigilance literature monitoring journey. Periodic surveillance of scientific and medical literature databases and publications from diverse local journals is conducted, encompassing both global literature monitoring and localized literature surveillance. Advanced algorithms categorize Individual Case Safety Reports (ICSRs) into valid, potential, and invalid cases, while automated key entity detection efficiently recognizes crucial entities like patients, medications, adverse events, and designated medical events. -
19
Healnet
Healx
Rare diseases are often not well studied and there is a limited understanding of many of the aspects necessary to support a drug discovery program. Our AI platform, Healnet, overcomes these challenges by analyzing millions of drug and disease data points to find novel connections that could be turned into new treatment opportunities. By applying frontier technologies across the discovery and development pipeline, we can run multiple stages in parallel and at scale. One disease, one target, one drug: it's an overly simple model, yet it's the one used by nearly all pharmaceutical companies. The next generation of drug discovery is AI-powered, parallel and hypothesis-free. Bringing together the key three drug discovery paradigms. -
20
Genomenon
Genomenon
Pharma companies need comprehensive genomic information to drive successful precision medicine programs, but decisions are often made using only a fraction of the data available, about 10%. Genomenon delivers 100% of the data. An efficient and cost-effective natural history research solution for pharma, ProdigyTM Patient Landscapes support the development of rare disease therapies by enhancing insights contained in retrospective and prospective health data. Using a powerful AI-driven approach, Genomenon delivers a comprehensive and expert assessment of every patient in the published medical literature, in a fraction of the time. Don’t miss anything, get insight into every genomic biomarker published in the medical literature. Every scientific assertion is supported by empirical evidence from the medical literature. Identify all genetic drivers and pinpoint which variants are known to be pathogenic according to ACMG clinical standards. -
21
Embase
Elsevier
Improve your biomedical research with the world’s most comprehensive biomedical literature database. More biomedical evidence by searching comprehensive, relevant, and up-to-date biomedical research. Create systematic searches and automate query building using intuitive search forms. Uncover drug-disease relationships and drug-drug interactions, manually curated from deep indexing. The accelerated pace of biomedical research and development demands comprehensive information. You anticipate risk by assessing everything that is known. You track safety to meet regulations. You uncover connections to push innovations. Embase is a unique medical literature database where comprehensive goes beyond content. With Emtree indexing of full-text content and dedicated search terms, you find all relevant and current results. This includes information that may not be uncovered in other databases. Scroll down to find out why regulatory agencies recommend Embase in their best practice guidelines. -
22
Edison Scientific
Edison Scientific
Edison Scientific is an AI platform designed to automate and accelerate scientific research, enabling users to move from hypothesis to validated results within a single environment. The platform integrates literature synthesis, data analysis, and molecular design workflows, allowing research teams to complete end-to-end scientific investigations at dramatically increased speed. At its core is Kosmos, an autonomous research system that performs hundreds of research tasks in parallel, transforming multimodal datasets into comprehensive reports with validated findings and publication-ready figures. Kosmos synthesizes scientific literature, public databases, and proprietary datasets, identifies novel therapeutic targets, uncovers biological mechanisms, and supports the iterative design and optimization of molecular candidates. Validated in real research settings, Kosmos has demonstrated the ability to achieve results that typically require months of human effort in a single day.Starting Price: $50 per month -
23
Schrödinger
Schrödinger
Transform drug discovery and materials research with advanced molecular modeling. Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space. Our platform is deployed by industry leaders worldwide for drug discovery, as well as for materials science in fields as diverse as aerospace, energy, semiconductors, and electronics displays. The platform powers our own drug discovery efforts, from target identification to hit discovery to lead optimization. It also drives our research collaborations to develop novel medicines for critical public health needs. With more than 150 Ph.D. scientists on our team, we invest heavily in R&D. We’ve published over 400 peer-reviewed papers that demonstrate the strength of our physics-based approaches, and we’re continually pushing the limits of computer modeling. -
24
Claude for Life Sciences
Anthropic
Claude for Life Sciences is an AI-powered research platform developed by Anthropic, tailored explicitly for life sciences workflows such as drug discovery, experimental design, and regulatory documentation. The solution connects Claude’s large-language-model capabilities with key research environments and data sources, linking to platforms like lab information systems, genomic analysis tools, and biomedical databases, so scientists can move seamlessly from hypothesis generation through data interpretation to publication-ready outputs. The system also introduces “skills” and specialized connectors built for life-science use cases; for example, a skill for single-cell RNA-seq quality control, or integration with spatial-biology toolchains, enabling meaningful dialogue with analytic pipelines rather than simply raw prompts. By embedding into existing workflows, it reports performance that exceeds human baseline on protocol comprehension tasks, supports natural-language queries. -
25
Edison Analysis
Edison Scientific
Edison Analysis is a next-generation scientific data-analysis agent built by Edison Scientific. It is the analytical engine underpinning their AI Scientist platform, Kosmos, and it’s available both on Edison’s platform and via API. Edison Analysis performs complex scientific data analysis by iteratively building and updating Jupyter notebooks in a dedicated environment; given a dataset plus a prompt, the agent explores, analyzes, and interprets the data to provide comprehensive insights, reports, and visualizations, very much like a human scientist. It supports execution of Python, R, and Bash code, and includes a full suite of common scientific-analysis packages in a Docker environment. Because all work is done within a notebook, the reasoning is fully transparent and auditable; users can inspect exactly how data was manipulated, which parameters were chosen, how conclusions were drawn, and can download the notebook and associated assets at any time.Starting Price: $50 per month -
26
Sapio Sciences
Sapio Sciences
Sapio Sciences delivers the Sapio Platform, an agentic AI lab informatics platform that makes life in the lab easier and more productive for scientists. The unified, configurable, low code and scalable environment brings together Sapio LIMS, the market’s most advanced and flexible LIMS for automating research, diagnostics and manufacturing, Sapio ELaiN, the third generation AI lab notebook and scientific co scientist, and Sapio Scientific Data Cloud, the scientific data unification solution with built in organization, search, charting, tools and AI. Biopharma R&D, biotech, CRO and clinical diagnostics organizations use Sapio to run complex workflows and keep samples, experiments and data connected in one place instead of juggling disconnected systems. -
27
Kosmos
Edison Scientific
Kosmos is the next-generation “AI Scientist” developed to perform autonomous discovery by reading vast amounts of scientific literature and executing code to reach novel conclusions. It uses structured world models to efficiently incorporate information gathered over hundreds of agent trajectories and maintain coherence throughout tens of millions of tokens, thereby transcending the context-length limits of earlier language-model-based tools. A typical Kosmos run might read about 1,500 papers and execute 42,000 lines of analysis code, enabling it to perform in one day what beta users estimated would take a human scientist six months. Its outputs are fully traceable; each conclusion in a Kosmos report can be linked to the specific lines of code and passages in the literature that inspired it, allowing for full auditability of its reasoning.Starting Price: $50 per month -
28
Illumina Connected Analytics
Illumina
Store, archive, manage, and collaborate on multi-omic datasets. Illumina Connected Analytics is a secure genomic data platform to operationalize informatics and drive scientific insights. Easily import, build, and edit workflows with tools like CWL and Nextflow. Leverage DRAGEN bioinformatics pipelines. Organize data in a secure workspace and share it globally in a compliant manner. Keep your data in your cloud environment while using our platform. Visualize and interpret your data with a flexible analysis environment, including JupyterLab Notebooks. Aggregate, query, and analyze sample and population data in a scalable data warehouse. Scale analysis operations by building, validating, automating, and deploying informatics pipelines. Reduce the time required to analyze genomic data, when swift results can be a critical factor. Enable comprehensive profiling to identify novel drug targets and drug response biomarkers. Flow data seamlessly from Illumina sequencing systems. -
29
PubHive Navigator
PubHive
PubHive Navigator is an AI-powered software platform that streamlines scientific literature and safety workflows for life science companies of all sizes. It offers centralized end-to-end workflow solutions for literature review, curation, annotation, collaboration, searching, reporting, citing, and managing research. The platform features AI-powered smart workspaces for centralized literature management, collaborative research writing and team communication, reuse rights and document delivery integrations, and out-of-the-box workflows for different operation units. PubHive Navigator is designed to simplify enterprise scientific literature and safety information workflows, making it a flexible software platform for teams in drug safety and pharmacovigilance, medical affairs, clinical affairs, and R&D. -
30
Noah AI
Noah AI
Noah AI is an AI-powered research assistant tailored specifically for life-sciences professionals, designed to automate and accelerate complex workflows across biomedical research, clinical development, and commercial strategy. It offers an “Agent” mode that plans and executes multi-step tasks by conducting intelligent web searches, querying trusted scientific databases (such as PubMed and FDA/NIH sources), summarizing high-impact papers, mining clinical-trial results, and generating professional-grade reports, while a lighter “Search” mode allows rapid, reliable access to domain-specific content summaries. With integrations across comprehensive medical/public-health data, AI-driven insights, and real-time news tracking of global R&D activity and conference intelligence, Noah AI enables researchers, biotech investors, and clinicians to go from question to insight in a fraction of the time.Starting Price: $12.40 per month -
31
Evo 2
Arc Institute
Evo 2 is a genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins. It utilizes a frontier deep learning architecture to model biological sequences at single-nucleotide resolution, achieving near-linear scaling of compute and memory relative to context length. Trained with 40 billion parameters and a 1 megabase context length, Evo 2 processes over 9 trillion nucleotides from diverse eukaryotic and prokaryotic genomes. This extensive training enables Evo 2 to perform zero-shot function prediction across multiple biological modalities, including DNA, RNA, and proteins, and to generate novel sequences with plausible genomic architecture. The model's capabilities have been demonstrated in tasks such as designing functional CRISPR systems and predicting disease-causing mutations in human genes. Evo 2 is publicly accessible via Arc's GitHub repository and is integrated into the NVIDIA BioNeMo framework. -
32
Chemaxon Design Hub
Chemaxon
A platform that connects scientific rationale, compound design, and computational resources. Chemaxon’s Design Hub for medicinal chemistry from analysis to prioritize ideas. Design Compounds and manage ideas within one platform. A single platform that connects scientific rationale, compound design, and computational resources. Switch from PowerPoint files to graphical and chemically searchable hypotheses that are an integral part of the compound design process. Easily work with your trusted phys-chem properties, computational models, novelty issues, or purchasable compound catalogs in a rich visual environment. Involve your CROs in the compound progression process using this secure online service. Analyze collected evidence from biological assays or experimental structural information, extract SAR, and make new hypotheses for the next optimization iteration. Store your scientific hypotheses in a “designer's ELN” (chemically aware drawing canvases). -
33
L7|ESP
L7 Informatics
L7 Enterprise Science Platform (L7|ESP®) is a unified platform that contextualizes data and eliminates business silos via process orchestration. It's a comprehensive solution that facilitates the digitalization of data and scientific processes in life sciences organizations. L7|ESP has native applications, including L7 LIMS, L7 Notebooks, L7 MES, L7 Scheduling, and more. It can integrate with existing third-party applications, lab instruments, and devices to capture all data in a single data model. It has a low-code/no-code workflow designer and hundreds of pre-built connectors to enable rapid time-to-value and end-to-end automation. By leveraging a single data model, L7|ESP enables advanced bioinformatics, AI, and ML to offer novel scientific and operational insights. L7|ESP addresses data and lab management needs in life sciences, particularly in: ● Research and Diagnostics ● Pharma and CDMO ● Clinical Sample Management Resource Center: l7informatics dot com/resource-center -
34
InSilicoTrials
InSilicoTrials
InSilicoTrials.com is a web-based platform, which provides a user-friendly computational modeling and simulation environment where many integrated easy-to-use in silico tools are readily available. The platform targets primarily users from the medical devices and pharmaceutical sectors. The in silico tools available for medical devices enable computational testing in different biomedical areas like radiology, orthopedics and cardiovascular during product design, development and validation processes. For the pharmaceutical sector, the platform provides access to in silico tools developed at all stages of the drug discovery and development processes and for many different therapeutic areas. We have built the only cloud-platform based on the crowdscience concept that makes it easy to use validated models and cut your R&D costs now. A growing catalogue of models ready to be used, on a pay per use basis. -
35
Mass Dynamics
Mass Dynamics
Discover biological biomarkers, create insights into disease mechanisms, discover new drugs or identify changes in protein levels from a set of carefully designed experiments. We’ve made it easy to start unlocking the power of MS and Proteomics so you can focus on the biological complexity and move closer to the moment of discovery. Our automated and repeatable workflow allows for quicker experiment startup and turnaround times, giving you the control and flexibility to make and act on decisions in the moment. Allowing you to focus on biological insights and human-to-human collaboration, our proteomics data processing workflow is built to scale, repeatedly. We’ve pushed heavy and repetitive processing to the cloud, enabling a seamless and enjoyable experience. Our intelligent Proteomics workflow seamlessly integrates complex moving parts to enable larger experiments to be processed and analyzed with ease. -
36
AIDDISON
Merck KGaA
AIDDISON™ drug discovery software combines the power of artificial intelligence (AI), machine learning (ML), and 3D computer-aided drug design (CADD) methods to act as a valuable toolkit for medicinal chemistry needs. As a unified platform for efficient and effective ligand-based and structure-based drug design, it integrates all the facets for virtual screening and supports methods for in-silico lead discovery and lead optimization. -
37
BIOiSIM
VERISIMLife
BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses. Our models are built on data from thousands of compounds across 7 species, leading to robustness rarely seen in the industry. With a focus on human outcomes, the platform has at its core a translatability engine that transforms insights across species. The BIOiSIMTM platform can be used before the preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation. -
38
Sciscoper
Sciscoper
Sciscoper is an AI powered research assistant that is used to streamline and accelerate the literature review process for STEM researchers, academics, and R&D teams. Researchers often deal with hundreds or thousands of scientific papers scattered across different sources, making it difficult to extract meaningful insights efficiently. Sciscoper solves this by using AI and natural language processing to automatically: Summarize scientific papers and research findings. Extract key insights, concepts, and relationships across documents. Generate literature reviews with citations in multiple reference styles. Organize and index papers into a structured, searchable knowledge base for easy discovery. This allows users to focus less on manual reading and note-taking, and more on analyzing results, identifying research gaps, and producing new scientific knowledge.Starting Price: $20/user/month -
39
NVIDIA Parabricks
NVIDIA
NVIDIA® Parabricks® is the only GPU-accelerated suite of genomic analysis applications that delivers fast and accurate analysis of genomes and exomes for sequencing centers, clinical teams, genomics researchers, and high-throughput sequencing instrument developers. NVIDIA Parabricks provides GPU-accelerated versions of tools used every day by computational biologists and bioinformaticians—enabling significantly faster runtimes, workflow scalability, and lower compute costs. From FastQ to Variant Call Format (VCF), NVIDIA Parabricks accelerates runtimes across a series of hardware configurations with NVIDIA A100 Tensor Core GPUs. Genomic researchers can experience acceleration across every step of their analysis workflows, from alignment to sorting to variant calling. When more GPUs are used, a near-linear scaling in compute time is observed compared to CPU-only systems, allowing up to 107X acceleration. -
40
Kanteron
Kanteron Systems
Kanteron Platform ingested medical images, digital pathology slides, genomics sequences, and patient data from modalities, scanners, sequencers and databases, and provided a complete data toolkit to every team in hospital networks. Pharmacogenomics for adverse medication event prevention, and Precision Medicine application at the point of care: Incorporates sources of drug-gene interaction data that were previously only available in in accessible formats (e.g. tables in a PDF document), implementing the major Pharmacogenomic databases (like PharmGKB, CGI, DGIdb, OpenTargets...) Allows the user to refine their query to certain gene families, types of interactions, classes of drugs, etc. Flexible AI means you can choose the data set that best fits your use case, and apply it to your relevant medical images. -
41
Eidogen-Sertanty Target Informatics Platform (TIP)
Eidogen-Sertanty
Eidogen-Sertanty's Target Informatics Platform (TIP) is the world's first structural informatics system and knowledgebase that enables researchers with the ability to interrogate the druggable genome from a structural perspective. TIP amplifies the rapidly expanding body of experimental protein structure information and transforms structure-based drug discovery from a low-throughput, data-scarce discipline into a high-throughput, data-rich science. Designed to help bridge the knowledge gap between bioinformatics and cheminformatics, TIP supplies drug discovery researchers with a knowledge base of information that is both distinct from and highly complementary to information furnished by existing bio- and cheminformatics platforms. TIP's seamless integration of structural data management technology with unique target-to-lead calculation and analysis capabilities enhances all stages of the discovery pipeline. -
42
Aspect Analytics
Aspect Analytics
Aspect Analytics offers a spatial multi-omics platform for collaborative, cross-disciplinary data analysis and management. For research teams in drug development, biomarker discovery, pathology analysis, and beyond. Aspect Analytics enables breakthrough research and facilitates cross-disciplinary teamwork by bringing multi-omics data into a single-view, collaborative platform. Layer in different spatial omics measurements in one joint visualization, simultaneously. Our platform combines data from all your spatial multi-omics assays to ensure you get the insights you need. Store & manage petabytes of data, securely. Access it anytime, anywhere. Scale up and customize data infrastructure according to your needs. Integrate spatial biology data from different technologies and from all different vendors, no matter which data format. Set up automated workflows and run in-depth analyses on large datasets, in parallel. -
43
3decision
Discngine
3decision® is a cloud-based protein structure repository designed for comprehensive structural data management and advanced analytics, enabling small molecule and biologics discovery teams to accelerate structure-based drug design. It centralizes and standardizes experimental and in-silico protein structures from public sources like RCSB PDB and AlphaFoldDB, as well as proprietary data, supporting formats like PDBx/mmCIF and ModelCIF. This ensures easy access to X-Ray, NMR, cryo-EM, and modeled structures, fostering collaboration and enhancing research efforts. Beyond storage, 3decision® enriches entries with metadata and sequence information, including protein-ligand interactions, antibody annotations, and binding site details. Advanced analytical tools identify druggable sites, assess off-target risks, and enable binding site comparisons, transforming vast structural data into actionable knowledge. Its cloud-based platform facilitates collaboration among research teams. -
44
OmicsBox
BioBam Bioinformatics S.L.
OmicsBox is a leading bioinformatics solution that offers end-to-end data analysis of genomes, transcriptomes, metagenomes, and genetic variation studies. The application is used by top private and public research institutions worldwide and allows researchers to easily process large and complex data sets, and streamline their analysis process. It is designed to be user-friendly, efficient, and with a powerful set of tools to extract biological insights from omics data. The software is structured in different modules, each with a specific set of tools and functions designed to perform different types of analysis, such as de-novo genome assemblies, genetic variation analysis, differential expression analysis, and taxonomic classifications of microbiome data, including the functional interpretation and rich visualizations of results. The functional analysis module includes the popular Blast2GO annotation methodology and makes OmicsBox particularly suited for non-model organism researchStarting Price: €100/month/seat -
45
HeyScience
HeyScience
Finding, reading, and analyzing every relevant scientific research article can quickly turn into a time-consuming, tedious task. Designed by fellow academics, our AI-powered scientific research assistant lets you focus on what you love doing most: conducting research. Stay current with an overview of what researchers in your field are working on, familiarize yourself with a specific scientist’s contributions, and assess the possibility of future collaborations. Conduct a month’s worth of literature research in a few minutes. Search and sort through millions of papers across all academic fields to find relevant knowledge in one click. Read a short, simplified summary of scientific articles and grasp key concepts and findings within minutes. Leverage our dedicated AI-reviewer for instant feedback on your manuscript prior to conference or journal submission. -
46
Iktos
Iktos
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO). It enables the design of novel and easy-to-make compounds in line with a multi-objective blueprint with unprecedented speed, performance, and diversity. Makya offers multiple generative algorithms covering different use cases from hit discovery to lead optimization: fine-tuning generator to find optimal solutions within your chemical space in line with your project blueprint; novelty generator to find new ideas with high novelty for re-scaffolding/hit discovery; forward generator to design a focused library of compounds easily accessible from commercial starting materials. The new Makya 3D module enhances the user experience and scientific utility of Makya. With an extensive set of 3D modeling features in both ligand-based and structure-based pipelines, with Makya 3D you can now calculate 3D scores and use these to guide generations natively in Makya. -
47
CDD Vault
Collaborative Drug Discovery
With CDD Vault, you can intuitively organize chemical structures and biological study data, and collaborate with internal or external partners through an easy to use web interface. Start your free trial and see first hand how easy it is to manage drug discovery data. Tailored for you Affordable Scales with your project team(s) Activity & Registration * Electronic Lab Notebook (ELN) * Visualization * Inventory * APIs * Secure Online Hosting -
48
Dotmatics
Dotmatics
Dotmatics is the global leader in R&D scientific software that connects science, data, and decision-making. Combining a workflow and data platform with best-of-breed applications, we offer the first true end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more. Trusted by more than 2 million researchers from the world’s leading biopharma, chemicals and materials enterprises, and academic institutions, we are dedicated to working with the scientific community to help make the world a healthier, cleaner and safer place to live. Learn more about our platform and products, including GraphPad Prism, Geneious, SnapGene, Protein Metrics, LabArchives, and more. -
49
Microsoft Discovery
Microsoft
Microsoft Discovery is a new agentic platform designed to revolutionize research and development (R&D) by empowering scientists and engineers with AI-driven collaboration and high-performance computing (HPC). Built on Azure, this platform enables researchers to work alongside specialized AI agents that help accelerate the discovery process through advanced knowledge reasoning, hypothesis formulation, and experimental simulations. The platform's graph-based knowledge engine facilitates complex, contextual reasoning over vast amounts of scientific data, promoting transparency and accountability while speeding up the discovery cycle. By automating and enhancing research tasks, Microsoft Discovery offers an extensible, enterprise-ready solution that integrates seamlessly with existing tools and datasets. -
50
Prism
OpenAI
Prism is a free, LaTeX-native scientific writing workspace designed to streamline research collaboration and publishing. It brings drafting, compiling, and collaboration into a single cloud-based environment with no local setup required. Prism integrates GPT-5.2 directly into the writing workflow, providing AI-assisted proofreading, formatting, and literature search. Researchers can collaborate with unlimited contributors in real time while viewing instant compiled previews of their work. The platform is fully project-aware, allowing AI to understand the full context of a paper, including equations, references, and revisions. Built-in LaTeX rendering, citation management, and error checking reduce time spent on manual cleanup. Prism is designed to meet scientists where they already work, making it a modern standard for scientific writing.
